Relief in South Africa after J&J reversal allows key tuberculosis drug production at lower prices

4 months ago 4
Medical advocacy groups have welcomed Johnson & Johnson’s decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices
Read Entire Article